It's not likely that any mention of the Partial Clinical Hold will even be brought up by GK at the Pitch & Partner. Even if the data will be provided to the FDA by time of the meeting that would not overlook the fact that the FDA had issued a serious request for more information and it has taken an inordinately long time for Prana to respond.
Of course any potential collaborators will do their due diligence, at which time they will also learn of the NASDAQ noncompliance status.
Ann: Appendix 4D Half Yearly Report and Accounts, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.001(6.67%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.7¢ | 1.5¢ | $770.2K | 49.71M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2038332 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 349000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |